Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.59 |
| ▸ | MMP3 | P08254 | 5/20 | 0.56 |
| ▸ | MMP2 | P08253 | 7/20 | 0.56 |
| ▸ | MMP1 | P03956 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | MMP13 | P45452 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.47 |
| ▸ | HRH2 | P25021 | 4/20 | 0.47 |
| ▸ | HRH1 | P35367 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8939360 | 1.00 | HDAC1 (0.59) | HDAC1HDAC2MMP3MMP2MMP1 | |
| SCHEMBL8939370 | 1.00 | HDAC1 (0.59) | HDAC1HDAC2MMP3MMP2MMP1 | |
| SCHEMBL8939317 | 1.00 | HDAC1 (0.59) | HDAC1HDAC2MMP3MMP2MMP1 | |
| SCHEMBL8939373 | 1.00 | HDAC1 (0.59) | HDAC1HDAC2MMP3MMP2MMP1 | |
| SCHEMBL8939366 | 1.00 | HDAC1 (0.59) | HDAC1HDAC2MMP3MMP2MMP1 | |
| SCHEMBL8939353 | 1.00 | HDAC1 (0.59) | HDAC1HDAC2MMP3MMP2MMP1 | |
| SCHEMBL103263 | 1.00 | HDAC1 (0.59) | HDAC1HDAC2MMP3MMP2MMP1 | |
| SCHEMBL5961806 | 0.99 | MMP3 (0.58) | HDAC1HDAC2MMP3MMP2MMP1 | |
| SCHEMBL4331061 | 0.96 | MMP2 (0.57) | HDAC1HDAC2MMP3MMP2MMP1 | |
| SCHEMBL2241855 | 0.94 | THRB (0.56) | HDAC1HDAC2MMP3MMP2MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11377596-B2 | Liquid-crystalline media | MERCK PATENT GMBH (DE) | 2022-07-05 | — | — | US | claimed |
| US-12624290-B2 | Method for reducing white flicker | MERCK PATENT GMBH (DE) | 2026-05-12 | — | — | US | disclosed |
| US-12618007-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2026-05-05 | — | — | US | disclosed |
| US-12618008-B2 | Liquid crystal medium | MERCK PATENT GMBH (DE) | 2026-05-05 | — | — | US | disclosed |
| US-12612551-B2 | Liquid crystal medium | MERCK PATENT GMBH (DE) | 2026-04-28 | — | — | US | disclosed |
| US-12595417-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2026-04-07 | — | — | US | disclosed |
| US-12559678-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2026-02-24 | — | — | US | disclosed |
| US-12552991-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2026-02-17 | — | — | US | disclosed |
| EP-4689003-A1 | METHOD | University of Leeds (GB) | 2026-02-11 | — | — | EP | disclosed |
| EP-4678715-A2 | LIQUID CRYSTAL MEDIUM | Merck Patent GmbH (DE) | 2026-01-14 | — | — | EP | disclosed |
| US-20170030785-A1 | STRESS MEASURING METHOD, STRESS MEASURING MEMBER, AND STRESS MEASURING SET | FUJIFILM CORPORATION (JP) | 2017-02-02 | — | — | US | disclosed |
| US-20170030785-A1 | STRESS MEASURING METHOD, STRESS MEASURING MEMBER, AND STRESS MEASURING SET | FUJIFILM CORPORATION (JP) | 2017-02-02 | — | — | US | disclosed |
| US-20160195655-A1 | POLARIZING PLATE FABRICATION METHOD | FUJIFILM CORPORATION (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160195655-A1 | POLARIZING PLATE FABRICATION METHOD | FUJIFILM CORPORATION (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160062014-A1 | POLARIZING PLATE AND METHOD FOR PRODUCING SAME, AND OPTICAL FILM MATERIAL | FUJIFILM CORPORATION (JP) | 2016-03-03 | — | — | US | disclosed |
| US-20160062014-A1 | POLARIZING PLATE AND METHOD FOR PRODUCING SAME, AND OPTICAL FILM MATERIAL | FUJIFILM CORPORATION (JP) | 2016-03-03 | — | — | US | disclosed |
| EP-0955348-B1 | LIQUID-CRYSTAL COMPOSITION AND POLYMERIC LIQUID CRYSTAL OBTAINED BY POLYMERIZING THE SAME | ASAHI GLASS CO LTD (JP) | 2002-10-23 | — | — | EP | disclosed |
| US-6180028-B1 | ACRYLATED ESTERS | ASAHI GLASS COMPANY LTD. (JP) | 2001-01-30 | — | — | US | disclosed |
| EP-0955348-A1 | LIQUID-CRYSTAL COMPOSITION AND POLYMERIC LIQUID CRYSTAL OBTAINED BY POLYMERIZING THE SAME | Asahi Glass Company Ltd. (JP) | 1999-11-10 | — | — | EP | disclosed |
| US-5498363-A | Electrorheological fluid | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1996-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559678-B2 | Liquid-crystal medium | SCO2, CFD, CLCN2 | HDAC1 3854/4885HDAC2 3212/4885MMP3 2553/4885 |
| US-12552991-B2 | Liquid-crystalline medium | FES, VIM, INHA | HDAC1 3665/4885HDAC2 3235/4885MMP3 1828/4885 |
| US-12618007-B2 | Liquid-crystalline medium | SOST, NES, VIM | HDAC1 3032/4885HDAC2 2625/4885MMP3 724/4885 |
| US-12595417-B2 | Liquid-crystal medium | MEF2D, HCN2, HCN3 | HDAC1 3936/4885HDAC2 2635/4885MMP3 3203/4885 |
| US-12612551-B2 | Liquid crystal medium | FES, VIM, NES | HDAC1 3948/4885HDAC2 3802/4885MMP3 1578/4885 |
| US-12624290-B2 | Method for reducing white flicker | HCN4, HCN2, HCN3 | HDAC1 1654/4885HDAC2 852/4885MMP3 3359/4885 |
| US-12618008-B2 | Liquid crystal medium | VIM, FES, NES | HDAC1 3257/4885HDAC2 3238/4885MMP3 1512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.